UWSpace staff members will be away from May 5th to 9th, 2025. We will not be responding to emails during this time. If there are any urgent issues, please contact GSPA at gsrecord@uwaterloo.ca. If any login or authentication issues arise during this time, please wait until UWSpace Staff members return on May 12th for support.

Pharmacy Residency Papers

Permanent URI for this collectionhttps://hdl.handle.net/10012/21569

The Canadian Pharmacy Residency Board requires that pharmacy residents conduct a research project during their residency, and that a report detailing this work be submitted at the conclusion of the residency. Beginning in 2020, papers completed in the course of fulfilling residencies administered by the University of Waterloo School of Pharmacy will be archived in UWSpace, the University of Waterloo’s open access research repository.

Visit the Pharmacy Resident Paper Submission page on the School of Pharmacy's website to submit your residency paper to UWSpace.

Browse

Browsing Pharmacy Residency Papers by Author "Panic, Gea"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Risk and Benefit of Warfarin for Primary Prevention in Atrial Fibrillation Patients on Hemodialysis: A Retrospective Pilot Study
    (University of Waterloo, 2020-07-17) Panic, Gea; McNorton, Kelly; Yrigoyen-Dacruz, Lidia; Duronio, Antoinette
    Background Despite increased awareness and advocacy regarding the opioid epidemic, data from Health Quality Ontario (HQO) shows steady prescribing of opioids with concerning trends toward prescribing more potent opioids. The creation of a quality standard for Opioid Prescribing in Acute Pain provides opportunity for organizations to assess whether they are meeting best practice recommendations. Objective To examine opioid prescribing patterns for patients presenting to the emergency department (ED) and to assess opioid prescribing at discharge in comparison to HQO quality standards. Methods This retrospective, observational study examined adults presenting to two ED sites within in a multi-site community teaching hospital. Patients prescribed intravenous (IV)/intramuscular (IM)/subcutaneous (SC) morphine, hydromorphone, and fentanyl were included. Patients were excluded if intubated, palliative or end-of-life, being treated for overdose, multi-fracture trauma, or admitted for inpatient treatment. Results Opioids were administered to 200 patients, with 12 patients receiving two different opioids (n=212). The most common opioid was morphine (79.7%), route was intravenous (92.9%), and frequency was as a one-time dose (46.2%). Common indications included abdominal pain (32%), trauma (11%), and renal/biliary colic (10.5%). A median parenteral morphine equivalent (MEQ) of 5 mg (IQR, 4-6.67 mg) was given, with 33.5% of patients receiving concurrent non-opioid pain management. Patients who received hydromorphone (OR 6.37), were prescribed as needed (OR 2.32), scheduled (OR 30.81) or repeated doses (OR 3.95), and had an indication of migraine or headache (OR 8.92) were more likely to receive higher doses. At discharge, one in four patients received an opioid prescription, most commonly for acetaminophen/oxycodone 325/5 mg (46%) or acetaminophen/caffeine/codeine 300/15/30 mg (36%) with a median duration of 3.1 days. Conclusion In summary, our organization showed reassuring prescribing patterns, meeting HQO quality standards for dose and duration of discharge prescription.